nAChR-IN-1 (hydrochloride) is a selective nicotinic acetylcholine receptor (nAChR) inhibitor that suppresses nAChRs lacking α5, α6, or β3 subunits; it exhibits neuroprotective effects and can be used in the study of nicotinic acetylcholine receptor dysfunction and neurological disorders.